Intellectual Property India Publishes Patent Application for Pharmaceutical Compositions Of Anti-Il-13 Antibodies With And Without C- Terminal Lysine

MUMBAI, India, July 7 -- Intellectual Property India has published a patent application (202647078374 A) filed by Apogee Therapeutics, Inc. on June 25, 2026, for Pharmaceutical Compositions Of Anti-Il-13 Antibodies With And Without C- Terminal Lysine.

Inventors include Shaheen, Hussam, Hisham; Thompson, Kenneth, Evan; Harwin, Peter Evan Number; Kiselak, Tomas; Dabora, Rebecca, Lucille; and Prentice, Holly.

The application for the patent was published on July 03, 2026, under issue no. 27/2026.

Abstract: Described herein are pharmaceutical compositions of anti-interleukin (IL)-13 antibodies comprising a mixture of antibodies with and without C-terminal lysine extension. Also provided are pharmaceutical compositions for use in the treatment...